China Pharmaceutical Trade: Other Biochemicals and Western Medicines
Export: Agar
CN: Export: Agar data was reported at 5,394.689 USD th in Sep 2024. This records a decrease from the previous number of 7,096.203 USD th for Aug 2024. CN: Export: Agar data is updated monthly, averaging 6,213.992 USD th from Jan 2010 (Median) to Sep 2024, with 177 observations. The data reached an all-time high of 11,636.171 USD th in Jan 2015 and a record low of 2,552.000 USD th in Feb 2010. CN: Export: Agar data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 5,394.689 Sep 2024 | monthly | Jan 2010 - Sep 2024 |
View China's Export: Agar from Jan 2010 to Sep 2024 in the chart:
Export: Bacteria & Virus under Sensitive Item Control
CN: Export: Bacteria & Virus under Sensitive Item Control data was reported at 0.000 USD th in Jan 2018. This stayed constant from the previous number of 0.000 USD th for Jan 2017. CN: Export: Bacteria & Virus under Sensitive Item Control data is updated monthly, averaging 0.000 USD th from Feb 2012 (Median) to Jan 2018, with 9 observations. The data reached an all-time high of 0.005 USD th in Oct 2015 and a record low of 0.000 USD th in Jan 2018. CN: Export: Bacteria & Virus under Sensitive Item Control data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Jan 2018 | monthly | Feb 2012 - Jan 2018 |
View China's Export: Bacteria & Virus under Sensitive Item Control from Feb 2012 to Jan 2018 in the chart:
Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale)
CN: Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data was reported at 0.000 USD th in Dec 2016. This stayed constant from the previous number of 0.000 USD th for Sep 2016. CN: Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data is updated monthly, averaging 0.000 USD th from Mar 2014 (Median) to Dec 2016, with 9 observations. The data reached an all-time high of 0.000 USD th in Dec 2016 and a record low of 0.000 USD th in Dec 2016. CN: Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Dec 2016 | monthly | Mar 2014 - Dec 2016 |
View China's Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale) from Mar 2014 to Dec 2016 in the chart:
Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer)
CN: Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data was reported at 1,375.028 USD th in Dec 2016. This records a decrease from the previous number of 2,155.338 USD th for Nov 2016. CN: Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data is updated monthly, averaging 1,146.273 USD th from Jan 2014 (Median) to Dec 2016, with 36 observations. The data reached an all-time high of 2,370.202 USD th in Mar 2014 and a record low of 547.281 USD th in May 2014. CN: Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 1,375.028 Dec 2016 | monthly | Jan 2014 - Dec 2016 |
View China's Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) from Jan 2014 to Dec 2016 in the chart:
China Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal
CN: Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data was reported at 0.050 USD th in Feb 2018. This records a decrease from the previous number of 0.093 USD th for Dec 2017. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data is updated monthly, averaging 0.093 USD th from Jan 2011 (Median) to Feb 2018, with 65 observations. The data reached an all-time high of 21.045 USD th in Sep 2011 and a record low of 0.000 USD th in Mar 2016. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.050 Feb 2018 | monthly | Jan 2011 - Feb 2018 |
View China's China Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal from Jan 2011 to Feb 2018 in the chart:
Export: Extract of Gland or Other Organ or of their Secretion, of Human
CN: Export: Extract of Gland or Other Organ or of their Secretion, of Human data was reported at 399.482 USD th in Mar 2018. This records a decrease from the previous number of 1,038.644 USD th for Feb 2018. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Human data is updated monthly, averaging 575.878 USD th from Jan 2011 (Median) to Mar 2018, with 87 observations. The data reached an all-time high of 2,220.784 USD th in Jan 2017 and a record low of 0.000 USD th in Apr 2016. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Human data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 399.482 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's Export: Extract of Gland or Other Organ or of their Secretion, of Human from Jan 2011 to Mar 2018 in the chart:
Export: Extract of Gland or Other Organ or of their Secretion, of Others
CN: Export: Extract of Gland or Other Organ or of their Secretion, of Others data was reported at 810.813 USD th in Mar 2018. This records an increase from the previous number of 696.714 USD th for Feb 2018. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Others data is updated monthly, averaging 568.576 USD th from Jan 2011 (Median) to Mar 2018, with 87 observations. The data reached an all-time high of 1,700.469 USD th in Mar 2013 and a record low of 0.256 USD th in Feb 2014. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Others data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 810.813 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's Export: Extract of Gland or Other Organ or of their Secretion, of Others from Jan 2011 to Mar 2018 in the chart:
Export: Insulin-Like Growth Factors-1
CN: Export: Insulin-Like Growth Factors-1 data was reported at 0.000 USD th in May 2016. This stayed constant from the previous number of 0.000 USD th for Dec 2015. CN: Export: Insulin-Like Growth Factors-1 data is updated monthly, averaging 0.000 USD th from Mar 2014 (Median) to May 2016, with 12 observations. The data reached an all-time high of 0.000 USD th in May 2016 and a record low of 0.000 USD th in May 2016. CN: Export: Insulin-Like Growth Factors-1 data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.000 May 2016 | monthly | Mar 2014 - May 2016 |
View China's Export: Insulin-Like Growth Factors-1 from Mar 2014 to May 2016 in the chart:
Export: Medicament Containing Artemisinin & their Derivative
CN: Export: Medicament Containing Artemisinin & their Derivative data was reported at 9,206.350 USD th in Dec 2020. This records a decrease from the previous number of 15,873.820 USD th for Nov 2020. CN: Export: Medicament Containing Artemisinin & their Derivative data is updated monthly, averaging 5,546.564 USD th from Jan 2009 (Median) to Dec 2020, with 96 observations. The data reached an all-time high of 15,873.820 USD th in Nov 2020 and a record low of 0.000 USD th in Jan 2009. CN: Export: Medicament Containing Artemisinin & their Derivative data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 9,206.350 Dec 2020 | monthly | Jan 2009 - Dec 2020 |
View China's Export: Medicament Containing Artemisinin & their Derivative from Jan 2009 to Dec 2020 in the chart:
Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose
CN: Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose data was reported at 12.500 USD th in Dec 2020. This records a decrease from the previous number of 104.681 USD th for Nov 2020. CN: Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose data is updated monthly, averaging 46.815 USD th from Jan 2009 (Median) to Dec 2020, with 72 observations. The data reached an all-time high of 1,895.436 USD th in Jul 2011 and a record low of 0.000 USD th in Aug 2016. CN: Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 12.500 Dec 2020 | monthly | Jan 2009 - Dec 2020 |
View China's Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose from Jan 2009 to Dec 2020 in the chart:
Export: Medicament Containing Quinine & its Salt, Not in Measured Dose
CN: Export: Medicament Containing Quinine & its Salt, Not in Measured Dose data was reported at 30.448 USD th in Dec 2016. This records an increase from the previous number of 0.000 USD th for Nov 2016. CN: Export: Medicament Containing Quinine & its Salt, Not in Measured Dose data is updated monthly, averaging 1.833 USD th from Jan 2012 (Median) to Dec 2016, with 20 observations. The data reached an all-time high of 38.841 USD th in Apr 2012 and a record low of 0.000 USD th in Nov 2016. CN: Export: Medicament Containing Quinine & its Salt, Not in Measured Dose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 30.448 Dec 2016 | monthly | Jan 2012 - Dec 2016 |
View China's Export: Medicament Containing Quinine & its Salt, Not in Measured Dose from Jan 2012 to Dec 2016 in the chart:
Export: Medicament Containing Taxinol
CN: Export: Medicament Containing Taxinol data was reported at 0.000 USD th in Mar 2018. This records a decrease from the previous number of 1,285.462 USD th for Feb 2018. CN: Export: Medicament Containing Taxinol data is updated monthly, averaging 38.152 USD th from Jan 2011 (Median) to Mar 2018, with 86 observations. The data reached an all-time high of 6,436.913 USD th in Sep 2015 and a record low of 0.000 USD th in Mar 2018. CN: Export: Medicament Containing Taxinol data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's Export: Medicament Containing Taxinol from Jan 2011 to Mar 2018 in the chart:
China Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose
CN: Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data was reported at 29,095.438 USD th in Dec 2016. This records an increase from the previous number of 24,433.772 USD th for Nov 2016. CN: Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data is updated monthly, averaging 19,425.300 USD th from Jan 2011 (Median) to Dec 2016, with 72 observations. The data reached an all-time high of 29,095.438 USD th in Dec 2016 and a record low of 9,910.714 USD th in Oct 2011. CN: Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 29,095.438 Dec 2016 | monthly | Jan 2011 - Dec 2016 |
View China's China Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose from Jan 2011 to Dec 2016 in the chart:
Export: Other Antisera, Other Blood Fractions & Modified Immunological Product
CN: Export: Other Antisera, Other Blood Fractions & Modified Immunological Product data was reported at 196,535.668 USD th in Dec 2016. This records an increase from the previous number of 36,602.086 USD th for Nov 2016. CN: Export: Other Antisera, Other Blood Fractions & Modified Immunological Product data is updated monthly, averaging 24,969.798 USD th from Jan 2012 (Median) to Dec 2016, with 60 observations. The data reached an all-time high of 196,535.668 USD th in Dec 2016 and a record low of 11,953.726 USD th in Mar 2012. CN: Export: Other Antisera, Other Blood Fractions & Modified Immunological Product data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 196,535.668 Dec 2016 | monthly | Jan 2012 - Dec 2016 |
View China's Export: Other Antisera, Other Blood Fractions & Modified Immunological Product from Jan 2012 to Dec 2016 in the chart:
China Export: Other Bacteria & Virus
CN: Export: Other Bacteria & Virus data was reported at 769.824 USD th in Mar 2018. This records an increase from the previous number of 515.054 USD th for Feb 2018. CN: Export: Other Bacteria & Virus data is updated monthly, averaging 70.650 USD th from Jan 2009 (Median) to Mar 2018, with 109 observations. The data reached an all-time high of 1,593.488 USD th in Jan 2018 and a record low of 0.000 USD th in Feb 2011. CN: Export: Other Bacteria & Virus data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 769.824 Mar 2018 | monthly | Jan 2009 - Mar 2018 |
View China's China Export: Other Bacteria & Virus from Jan 2009 to Mar 2018 in the chart:
Export: Other Insulin & its Salt
CN: Export: Other Insulin & its Salt data was reported at 458.649 USD th in Sep 2024. This records an increase from the previous number of 337.956 USD th for Aug 2024. CN: Export: Other Insulin & its Salt data is updated monthly, averaging 8.500 USD th from Mar 2011 (Median) to Sep 2024, with 101 observations. The data reached an all-time high of 4,168.548 USD th in Dec 2011 and a record low of 0.000 USD th in Mar 2018. CN: Export: Other Insulin & its Salt data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 458.649 Sep 2024 | monthly | Mar 2011 - Sep 2024 |
View China's Export: Other Insulin & its Salt from Mar 2011 to Sep 2024 in the chart:
Export: Other Medicament, in Measured Dose
CN: Export: Other Medicament, in Measured Dose data was reported at 133,171.900 USD th in Dec 2014. This records a decrease from the previous number of 161,009.937 USD th for Nov 2014. CN: Export: Other Medicament, in Measured Dose data is updated monthly, averaging 128,216.740 USD th from Jan 2011 (Median) to Dec 2014, with 48 observations. The data reached an all-time high of 161,329.209 USD th in Mar 2014 and a record low of 44,564.586 USD th in Feb 2011. CN: Export: Other Medicament, in Measured Dose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 133,171.900 Dec 2014 | monthly | Jan 2011 - Dec 2014 |
View China's Export: Other Medicament, in Measured Dose from Jan 2011 to Dec 2014 in the chart:
Export: Other Protein Substance & their Derivative
CN: Export: Other Protein Substance & their Derivative data was reported at 12,386.962 USD th in Sep 2024. This records a decrease from the previous number of 15,067.639 USD th for Aug 2024. CN: Export: Other Protein Substance & their Derivative data is updated monthly, averaging 39,369.935 USD th from Jan 2009 (Median) to Sep 2024, with 189 observations. The data reached an all-time high of 95,982.963 USD th in Jan 2022 and a record low of 0.000 USD th in Jan 2009. CN: Export: Other Protein Substance & their Derivative data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 12,386.962 Sep 2024 | monthly | Jan 2009 - Sep 2024 |
View China's Export: Other Protein Substance & their Derivative from Jan 2009 to Sep 2024 in the chart:
China Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29
CN: Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29 data was reported at 0.000 USD th in Mar 2018. This stayed constant from the previous number of 0.000 USD th for Feb 2018. CN: Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29 data is updated monthly, averaging 24.190 USD th from Jan 2011 (Median) to Mar 2018, with 86 observations. The data reached an all-time high of 677.309 USD th in Aug 2017 and a record low of 0.000 USD th in Mar 2018. CN: Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29 data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's China Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29 from Jan 2011 to Mar 2018 in the chart:
Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses
CN: Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses data was reported at 0.024 USD th in Mar 2018. This records a decrease from the previous number of 0.050 USD th for Feb 2018. CN: Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses data is updated monthly, averaging 0.013 USD th from Jan 2014 (Median) to Mar 2018, with 28 observations. The data reached an all-time high of 0.080 USD th in Nov 2016 and a record low of 0.002 USD th in Jan 2015. CN: Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.024 Mar 2018 | monthly | Jan 2014 - Mar 2018 |
View China's Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses from Jan 2014 to Mar 2018 in the chart:
China Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose
CN: Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data was reported at 7.011 USD th in Mar 2018. This records an increase from the previous number of 0.000 USD th for Jan 2018. CN: Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data is updated monthly, averaging 13.205 USD th from Mar 2012 (Median) to Mar 2018, with 67 observations. The data reached an all-time high of 464.751 USD th in Jan 2015 and a record low of 0.000 USD th in Jan 2018. CN: Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 7.011 Mar 2018 | monthly | Mar 2012 - Mar 2018 |
View China's China Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose from Mar 2012 to Mar 2018 in the chart:
China Export: Toxin under Sensitive Items Control
CN: Export: Toxin under Sensitive Items Control data was reported at 0.000 USD th in Mar 2018. This stayed constant from the previous number of 0.000 USD th for Jan 2018. CN: Export: Toxin under Sensitive Items Control data is updated monthly, averaging 0.000 USD th from Jan 2014 (Median) to Mar 2018, with 31 observations. The data reached an all-time high of 32.785 USD th in Dec 2015 and a record low of 0.000 USD th in Mar 2018. CN: Export: Toxin under Sensitive Items Control data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Mar 2018 | monthly | Jan 2014 - Mar 2018 |
View China's China Export: Toxin under Sensitive Items Control from Jan 2014 to Mar 2018 in the chart:
Import: Active Yeast
CN: Import: Active Yeast data was reported at 1,369.463 USD th in Sep 2024. This records an increase from the previous number of 584.760 USD th for Aug 2024. CN: Import: Active Yeast data is updated monthly, averaging 669.374 USD th from Jan 2008 (Median) to Sep 2024, with 201 observations. The data reached an all-time high of 2,811.162 USD th in Jun 2013 and a record low of 26.505 USD th in Feb 2015. CN: Import: Active Yeast data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 1,369.463 Sep 2024 | monthly | Jan 2008 - Sep 2024 |
View China's Import: Active Yeast from Jan 2008 to Sep 2024 in the chart:
China Import: Bacteria & Virus under Sensitive Item Control
CN: Import: Bacteria & Virus under Sensitive Item Control data was reported at 1.858 USD th in Jan 2018. This records an increase from the previous number of 1.750 USD th for Jan 2017. CN: Import: Bacteria & Virus under Sensitive Item Control data is updated monthly, averaging 0.088 USD th from Feb 2012 (Median) to Jan 2018, with 9 observations. The data reached an all-time high of 1.858 USD th in Jan 2018 and a record low of 0.000 USD th in Oct 2015. CN: Import: Bacteria & Virus under Sensitive Item Control data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 1.858 Jan 2018 | monthly | Feb 2012 - Jan 2018 |
View China's China Import: Bacteria & Virus under Sensitive Item Control from Feb 2012 to Jan 2018 in the chart:
China Import: Blood Preparation of Endangered Animal
CN: Import: Blood Preparation of Endangered Animal data was reported at 0.000 USD th in Mar 2018. This stayed constant from the previous number of 0.000 USD th for Feb 2018. CN: Import: Blood Preparation of Endangered Animal data is updated monthly, averaging 0.000 USD th from Jan 2011 (Median) to Mar 2018, with 86 observations. The data reached an all-time high of 1.558 USD th in Jan 2016 and a record low of 0.000 USD th in Mar 2018. CN: Import: Blood Preparation of Endangered Animal data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's China Import: Blood Preparation of Endangered Animal from Jan 2011 to Mar 2018 in the chart:
Import: Casein
CN: Import: Casein data was reported at 13,119.131 USD th in Sep 2024. This records a decrease from the previous number of 18,858.999 USD th for Aug 2024. CN: Import: Casein data is updated monthly, averaging 2,734.036 USD th from Jan 2008 (Median) to Sep 2024, with 201 observations. The data reached an all-time high of 27,300.505 USD th in Apr 2023 and a record low of 261.491 USD th in Feb 2009. CN: Import: Casein data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 13,119.131 Sep 2024 | monthly | Jan 2008 - Sep 2024 |
View China's Import: Casein from Jan 2008 to Sep 2024 in the chart:
Import: Caseinate & Other Casein Derivative, Casein Glue
CN: Import: Caseinate & Other Casein Derivative, Casein Glue data was reported at 20,871.502 USD th in Sep 2024. This records a decrease from the previous number of 34,380.873 USD th for Aug 2024. CN: Import: Caseinate & Other Casein Derivative, Casein Glue data is updated monthly, averaging 10,072.241 USD th from Jan 2008 (Median) to Sep 2024, with 201 observations. The data reached an all-time high of 38,976.444 USD th in Jun 2023 and a record low of 1,159.471 USD th in Jan 2009. CN: Import: Caseinate & Other Casein Derivative, Casein Glue data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 20,871.502 Sep 2024 | monthly | Jan 2008 - Sep 2024 |
View China's Import: Caseinate & Other Casein Derivative, Casein Glue from Jan 2008 to Sep 2024 in the chart:
Import: Compound Preparation, Containing Condeine, its Derivative & Salt
CN: Import: Compound Preparation, Containing Condeine, its Derivative & Salt data was reported at 2,196.260 USD th in Dec 2016. This records an increase from the previous number of 116.470 USD th for Nov 2016. CN: Import: Compound Preparation, Containing Condeine, its Derivative & Salt data is updated monthly, averaging 2,903.618 USD th from Jan 2011 (Median) to Dec 2016, with 69 observations. The data reached an all-time high of 9,702.759 USD th in Aug 2012 and a record low of 0.000 USD th in May 2015. CN: Import: Compound Preparation, Containing Condeine, its Derivative & Salt data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 2,196.260 Dec 2016 | monthly | Jan 2011 - Dec 2016 |
View China's Import: Compound Preparation, Containing Condeine, its Derivative & Salt from Jan 2011 to Dec 2016 in the chart:
Import: Contraceptive Preparation Based On Hormone
CN: Import: Contraceptive Preparation Based On Hormone data was reported at 19,606.544 USD th in Sep 2024. This records a decrease from the previous number of 36,268.920 USD th for Aug 2024. CN: Import: Contraceptive Preparation Based On Hormone data is updated monthly, averaging 5,558.570 USD th from Jan 2009 (Median) to Sep 2024, with 189 observations. The data reached an all-time high of 45,938.541 USD th in Sep 2023 and a record low of 0.000 USD th in Feb 2015. CN: Import: Contraceptive Preparation Based On Hormone data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 19,606.544 Sep 2024 | monthly | Jan 2009 - Sep 2024 |
View China's Import: Contraceptive Preparation Based On Hormone from Jan 2009 to Sep 2024 in the chart:
Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer)
CN: Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data was reported at 464.526 USD th in Dec 2016. This records an increase from the previous number of 98.785 USD th for Nov 2016. CN: Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data is updated monthly, averaging 182.344 USD th from Jan 2014 (Median) to Dec 2016, with 36 observations. The data reached an all-time high of 674.100 USD th in Dec 2014 and a record low of 0.000 USD th in May 2016. CN: Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 464.526 Dec 2016 | monthly | Jan 2014 - Dec 2016 |
View China's Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) from Jan 2014 to Dec 2016 in the chart:
China Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal
CN: Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data was reported at 0.000 USD th in Feb 2018. This stayed constant from the previous number of 0.000 USD th for Dec 2017. CN: Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data is updated monthly, averaging 0.000 USD th from Jan 2011 (Median) to Feb 2018, with 65 observations. The data reached an all-time high of 0.030 USD th in Nov 2012 and a record low of 0.000 USD th in Feb 2018. CN: Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.000 Feb 2018 | monthly | Jan 2011 - Feb 2018 |
View China's China Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal from Jan 2011 to Feb 2018 in the chart:
China Import: Insulin-Like Growth Factors-1
CN: Import: Insulin-Like Growth Factors-1 data was reported at 0.533 USD th in May 2016. This records a decrease from the previous number of 0.574 USD th for Dec 2015. CN: Import: Insulin-Like Growth Factors-1 data is updated monthly, averaging 12.513 USD th from Mar 2014 (Median) to May 2016, with 12 observations. The data reached an all-time high of 132.476 USD th in Aug 2014 and a record low of 0.059 USD th in Mar 2014. CN: Import: Insulin-Like Growth Factors-1 data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.533 May 2016 | monthly | Mar 2014 - May 2016 |
View China's China Import: Insulin-Like Growth Factors-1 from Mar 2014 to May 2016 in the chart:
Import: Medicament Containing Artemisinin & their Derivative
CN: Import: Medicament Containing Artemisinin & their Derivative data was reported at 4.808 USD th in Nov 2020. This records an increase from the previous number of 0.000 USD th for Dec 2016. CN: Import: Medicament Containing Artemisinin & their Derivative data is updated monthly, averaging 0.000 USD th from Jan 2009 (Median) to Nov 2020, with 92 observations. The data reached an all-time high of 566.425 USD th in Jun 2009 and a record low of 0.000 USD th in Dec 2016. CN: Import: Medicament Containing Artemisinin & their Derivative data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 4.808 Nov 2020 | monthly | Jan 2009 - Nov 2020 |
View China's Import: Medicament Containing Artemisinin & their Derivative from Jan 2009 to Nov 2020 in the chart:
China Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose
CN: Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data was reported at 10,507.459 USD th in Dec 2016. This records a decrease from the previous number of 23,923.061 USD th for Nov 2016. CN: Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data is updated monthly, averaging 18,063.950 USD th from Jan 2011 (Median) to Dec 2016, with 72 observations. The data reached an all-time high of 36,984.741 USD th in Aug 2011 and a record low of 7,280.851 USD th in Jan 2016. CN: Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 10,507.459 Dec 2016 | monthly | Jan 2011 - Dec 2016 |
View China's China Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose from Jan 2011 to Dec 2016 in the chart:
Import: Other Albumin & its Salt
CN: Import: Other Albumin & its Salt data was reported at 1,079.803 USD th in Sep 2024. This records an increase from the previous number of 567.748 USD th for Aug 2024. CN: Import: Other Albumin & its Salt data is updated monthly, averaging 286.182 USD th from Jan 2009 (Median) to Sep 2024, with 189 observations. The data reached an all-time high of 4,709.743 USD th in Apr 2024 and a record low of 0.000 USD th in Jan 2009. CN: Import: Other Albumin & its Salt data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 1,079.803 Sep 2024 | monthly | Jan 2009 - Sep 2024 |
View China's Import: Other Albumin & its Salt from Jan 2009 to Sep 2024 in the chart:
Import: Other Antisera, Other Blood Fractions & Modified Immunological Product
CN: Import: Other Antisera, Other Blood Fractions & Modified Immunological Product data was reported at 518,281.186 USD th in Dec 2016. This records a decrease from the previous number of 524,100.851 USD th for Nov 2016. CN: Import: Other Antisera, Other Blood Fractions & Modified Immunological Product data is updated monthly, averaging 275,510.844 USD th from Jan 2012 (Median) to Dec 2016, with 60 observations. The data reached an all-time high of 611,170.844 USD th in Dec 2015 and a record low of 76,453.008 USD th in Jan 2012. CN: Import: Other Antisera, Other Blood Fractions & Modified Immunological Product data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 518,281.186 Dec 2016 | monthly | Jan 2012 - Dec 2016 |
View China's Import: Other Antisera, Other Blood Fractions & Modified Immunological Product from Jan 2012 to Dec 2016 in the chart:
China Import: Other Bacteria & Virus
CN: Import: Other Bacteria & Virus data was reported at 27,444.124 USD th in Mar 2018. This records an increase from the previous number of 10,548.710 USD th for Feb 2018. CN: Import: Other Bacteria & Virus data is updated monthly, averaging 6,726.249 USD th from Jan 2009 (Median) to Mar 2018, with 111 observations. The data reached an all-time high of 27,444.124 USD th in Mar 2018 and a record low of 0.000 USD th in Jan 2009. CN: Import: Other Bacteria & Virus data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 27,444.124 Mar 2018 | monthly | Jan 2009 - Mar 2018 |
View China's China Import: Other Bacteria & Virus from Jan 2009 to Mar 2018 in the chart:
China Import: Other Genetic Material & Gene-modified Organism
CN: Import: Other Genetic Material & Gene-modified Organism data was reported at 2,386.022 USD th in Mar 2018. This records an increase from the previous number of 1,130.250 USD th for Feb 2018. CN: Import: Other Genetic Material & Gene-modified Organism data is updated monthly, averaging 1,056.006 USD th from Jan 2011 (Median) to Mar 2018, with 87 observations. The data reached an all-time high of 3,596.019 USD th in Dec 2017 and a record low of 28.120 USD th in Jan 2012. CN: Import: Other Genetic Material & Gene-modified Organism data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 2,386.022 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's China Import: Other Genetic Material & Gene-modified Organism from Jan 2011 to Mar 2018 in the chart:
Import: Other Insulin & its Salt
CN: Import: Other Insulin & its Salt data was reported at 0.771 USD th in Jun 2024. This records a decrease from the previous number of 0.911 USD th for May 2024. CN: Import: Other Insulin & its Salt data is updated monthly, averaging 24,680.993 USD th from Mar 2011 (Median) to Jun 2024, with 131 observations. The data reached an all-time high of 228,235.802 USD th in May 2021 and a record low of 0.000 USD th in Nov 2017. CN: Import: Other Insulin & its Salt data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 0.771 Jun 2024 | monthly | Mar 2011 - Jun 2024 |
View China's Import: Other Insulin & its Salt from Mar 2011 to Jun 2024 in the chart:
Import: Other Single Preparation Containing Narcotic Drug of Chapter 29
CN: Import: Other Single Preparation Containing Narcotic Drug of Chapter 29 data was reported at 2,360.661 USD th in Mar 2018. This records an increase from the previous number of 977.959 USD th for Feb 2018. CN: Import: Other Single Preparation Containing Narcotic Drug of Chapter 29 data is updated monthly, averaging 2,206.985 USD th from Jan 2011 (Median) to Mar 2018, with 83 observations. The data reached an all-time high of 19,672.476 USD th in Nov 2016 and a record low of 0.000 USD th in Dec 2017. CN: Import: Other Single Preparation Containing Narcotic Drug of Chapter 29 data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 2,360.661 Mar 2018 | monthly | Jan 2011 - Mar 2018 |
View China's Import: Other Single Preparation Containing Narcotic Drug of Chapter 29 from Jan 2011 to Mar 2018 in the chart:
Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose
CN: Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data was reported at 676.855 USD th in Mar 2018. This records an increase from the previous number of 148.957 USD th for Jan 2018. CN: Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data is updated monthly, averaging 28.919 USD th from Mar 2012 (Median) to Mar 2018, with 67 observations. The data reached an all-time high of 4,434.812 USD th in Jun 2016 and a record low of 0.000 USD th in Aug 2017. CN: Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 676.855 Mar 2018 | monthly | Mar 2012 - Mar 2018 |
View China's Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose from Mar 2012 to Mar 2018 in the chart:
Import: Recombinant Human Insulin & its Salt
CN: Import: Recombinant Human Insulin & its Salt data was reported at 11.363 USD th in Sep 2024. This records a decrease from the previous number of 1,529.635 USD th for Jul 2024. CN: Import: Recombinant Human Insulin & its Salt data is updated monthly, averaging 7,070.723 USD th from Jan 2011 (Median) to Sep 2024, with 154 observations. The data reached an all-time high of 59,961.366 USD th in Feb 2019 and a record low of 0.000 USD th in May 2015. CN: Import: Recombinant Human Insulin & its Salt data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 11.363 Sep 2024 | monthly | Jan 2011 - Sep 2024 |
View China's Import: Recombinant Human Insulin & its Salt from Jan 2011 to Sep 2024 in the chart:
Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale)
CN: Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data was reported at 19,262.745 USD th in Dec 2016. This records an increase from the previous number of 9,734.486 USD th for Nov 2016. CN: Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data is updated monthly, averaging 3,378.697 USD th from Mar 2014 (Median) to Dec 2016, with 16 observations. The data reached an all-time high of 19,262.745 USD th in Dec 2016 and a record low of 12.389 USD th in Aug 2016. CN: Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 19,262.745 Dec 2016 | monthly | Mar 2014 - Dec 2016 |
View China's Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale) from Mar 2014 to Dec 2016 in the chart:
Import: Toxin under Sensitive Items Control
CN: Import: Toxin under Sensitive Items Control data was reported at 28,996.239 USD th in Mar 2018. This records a decrease from the previous number of 29,031.874 USD th for Jan 2018. CN: Import: Toxin under Sensitive Items Control data is updated monthly, averaging 13,564.839 USD th from Jan 2014 (Median) to Mar 2018, with 31 observations. The data reached an all-time high of 53,409.750 USD th in Jun 2017 and a record low of 0.000 USD th in Nov 2017. CN: Import: Toxin under Sensitive Items Control data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 28,996.239 Mar 2018 | monthly | Jan 2014 - Mar 2018 |
View China's Import: Toxin under Sensitive Items Control from Jan 2014 to Mar 2018 in the chart:
China Import: Venom Substance Prepared for Therapeutic or Prophylactic Use
CN: Import: Venom Substance Prepared for Therapeutic or Prophylactic Use data was reported at 66.150 USD th in Mar 2018. This stayed constant from the previous number of 66.150 USD th for Jan 2018. CN: Import: Venom Substance Prepared for Therapeutic or Prophylactic Use data is updated monthly, averaging 54.285 USD th from Jan 2011 (Median) to Mar 2018, with 62 observations. The data reached an all-time high of 149.805 USD th in Feb 2012 and a record low of 9.691 USD th in Dec 2013. CN: Import: Venom Substance Prepared for Therapeutic or Prophylactic Use data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.
| Last | Frequency | Range |
|---|---|---|
| 66.150 Mar 2018 | monthly | Jan 2011 - Mar 2018 |